{"id":"anavex3-71-oral-capsules","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"The drug activates sigma-1 receptors, which are involved in cellular stress response, mitochondrial function, and neuroinflammation. By engaging this target, ANAVEX3-71 is designed to provide neuroprotection and reduce neurodegeneration in neurodegenerative diseases. This mechanism is part of Anavex's broader platform targeting sigma-1 and muscarinic receptors for CNS disorders.","oneSentence":"ANAVEX3-71 is a sigma-1 receptor agonist that modulates neuroprotective and neuroinflammatory pathways in the central nervous system.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:56:35.719Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Alzheimer's disease"},{"name":"Parkinson's disease"}]},"trialDetails":[{"nctId":"NCT06245213","phase":"PHASE2","title":"A Study of ANAVEX3-71 in Adults With Schizophrenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anavex Life Sciences Corp.","startDate":"2024-03-15","conditions":"Schizophrenia","enrollment":71}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ANAVEX3-71 oral capsules","genericName":"ANAVEX3-71 oral capsules","companyName":"Anavex Life Sciences Corp.","companyId":"anavex-life-sciences-corp","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ANAVEX3-71 is a sigma-1 receptor agonist that modulates neuroprotective and neuroinflammatory pathways in the central nervous system. Used for Alzheimer's disease, Parkinson's disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}